Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience

Muhammed Gürgöze; AHG Muller-Hansma; Michelle Schreuder; JMH (Annette) Boers; Eric Boersma; Jeanine Roeters van Lennep

doi:10.1002/cpt.1193

Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience

Muhammed Gürgöze, AHG Muller-Hansma, Michelle Schreuder, JMH (Annette) Boers, Eric Boersma, Jeanine Roeters van Lennep

Research output: Contribution to journal › Article › Academic › peer-review

63 Citations (Scopus)

11 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	496-504
Number of pages	9
Journal	Clinical Pharmacology & Therapeutics
Volume	105
Issue number	2
DOIs	https://doi.org/10.1002/cpt.1193
Publication status	Published - 2019

Research programs

EMC COEUR-09

Access to Document

10.1002/cpt.1193

Clin Pharma and Therapeutics - 2018 - Gürgöze - Adverse Events Associated With PCSK9 Inhibitors A Real‐World ExperienceFinal published version, 256 KB

http://hdl.handle.net/1765/110197

Cite this

@article{c5ab2e47a5064054b20425c767a6b36f,

title = "Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience",

author = "Muhammed G{\"u}rg{\"o}ze and AHG Muller-Hansma and Michelle Schreuder and Boers, \{JMH (Annette)\} and Eric Boersma and \{Roeters van Lennep\}, Jeanine",

year = "2019",

doi = "10.1002/cpt.1193",

language = "Undefined/Unknown",

volume = "105",

pages = "496--504",

journal = "Clinical Pharmacology \& Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience

AU - Gürgöze, Muhammed

AU - Muller-Hansma, AHG

AU - Schreuder, Michelle

AU - Boers, JMH (Annette)

AU - Boersma, Eric

AU - Roeters van Lennep, Jeanine

PY - 2019

Y1 - 2019

U2 - 10.1002/cpt.1193

DO - 10.1002/cpt.1193

M3 - Article

C2 - 30053327

SN - 0009-9236

VL - 105

SP - 496

EP - 504

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

IS - 2

ER -